2018 annual financial data

Trevi Therapeutics 2018 Operating margin

Trevi Therapeutics 2018 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -18,408,000 USD and net income was -20,545,000 USD.
Operating cash flow was -18,291,000 USD.

Get free Trevi Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-18,408,000 USD
Net income
-20,545,000 USD
Operating cash flow
-18,291,000 USD